new england journal of medicine semaglutide NEJM on X: "In an interim analysis a phase 3 trial involving 800 patients with metabolic dysfunctionβassociated steatohepatitis, once-weekly improved liver histologic results at 72 weeks. Full ESSENCE trial results The New - ππ¨ππππ₯π ππ«ππ’ππ₯ππ¬
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 12 - Aug 17


















